Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 21, 2025 • 5:00 PM ET

Date/Time Source News Release
06/17/2025 08:41 AM EDT Newsfile Hemostemix Closes Private Placement of $469,366
05/20/2025 09:00 AM EDT Newsfile Hemostemix Presents at TERMIS 2025, Freiburg, Germany
05/12/2025 09:00 AM EDT Newsfile Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share
05/08/2025 09:12 AM EDT Newsfile Hemostemix at Invest Stuttgart
04/23/2025 11:53 AM EDT Newsfile Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio
03/17/2025 10:28 AM EDT Newsfile Hemostemix's Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial
03/14/2025 08:35 AM EDT GlobeNewswire Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
03/12/2025 01:12 PM EDT GlobeNewswire Life Sciences Investor Forum Agenda Announced for March 13th
03/06/2025 07:30 AM EST Newsfile Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
03/05/2025 07:45 AM EST Newsfile Hemostemix Sells Its 23rd ACP-01 Therapy Convertible Debenture
Page

Additional News

As of June 21, 2025 • 5:00 PM ET

Date/Time Source News Release
04/22/2025 04:15 PM EDT Investing News Network Top 5 Canadian Biotech Stocks in 2025
10/03/2024 10:00 AM EDT QM Canadian Market Movers Canadian Companies Moving the Markets, Morning edition
Thu, Oct 03, 2024 as of 10.00 am ET
09/04/2024 10:00 AM EDT QM Canadian Market Movers Canadian Companies Moving the Markets, Morning edition
Wed, Sep 04, 2024 as of 10.00 am ET
06/03/2024 01:23 PM EDT y%wire Financing & Partnership News Send Shares of this Stem-Cell Therapy Company on a Tear
04/24/2024 10:00 AM EDT QM Canadian Market Movers Canadian Companies Moving the Markets, Morning edition
Wed, Apr 24, 2024 as of 10.00 am ET
05/11/2022 11:53 AM EDT Baystreet Hemostemix, Leucrotta Lone Stocks at 52-Week Highs
04/21/2021 09:00 AM EDT Stockhouse The Latest Biotech Investment Opportunity is the Next Generation of Regenerative Medicine
02/11/2021 09:00 AM EST Stockhouse Shaping the Future of Regenerative Medicine Today
12/15/2020 09:00 AM EST Stockhouse Hemostemix Founder: A Man with a Compassionate Heart
12/09/2020 09:00 AM EST Stockhouse Shaping the Future of Medicine by Delivering Regenerative Medicines
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.